T. Rowe Price Associates’s Baker Hughes BKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $768M | Buy |
12,577,340
+941,560
| +8% | +$54.4M | 0.09% | 183 |
|
|
2025
Q4 | $530M | Buy |
11,635,780
+4,278,573
| +58% | +$203M | 0.06% | 247 |
|
|
2025
Q3 | $358M | Sell |
7,357,207
-320,823
| -4% | -$14.2M | 0.04% | 330 |
|
|
2025
Q2 | $294M | Sell |
7,678,030
-3,502,071
| -31% | -$132M | 0.03% | 358 |
|
|
2025
Q1 | $491M | Sell |
11,180,101
-1,415,638
| -11% | -$63.2M | 0.06% | 272 |
|
|
2024
Q4 | $517M | Sell |
12,595,739
-1,832,844
| -13% | -$73.9M | 0.06% | 262 |
|
|
2024
Q3 | $522M | Sell |
14,428,583
-6,728,160
| -32% | -$236M | 0.06% | 269 |
|
|
2024
Q2 | $744M | Buy |
21,156,743
+3,791,748
| +22% | +$124M | 0.09% | 201 |
|
|
2024
Q1 | $582M | Buy |
17,364,995
+4,207,973
| +32% | +$130M | 0.07% | 252 |
|
|
2023
Q4 | $450M | Buy |
13,157,022
+383,995
| +3% | +$13.1M | 0.06% | 276 |
|
|
2023
Q3 | $451M | Buy |
12,773,027
+1,394,760
| +12% | +$49.4M | 0.07% | 251 |
|
|
2023
Q2 | $360M | Buy |
11,378,267
+8,276,717
| +267% | +$241M | 0.05% | 290 |
|
|
2023
Q1 | $89.5M | Buy |
3,101,550
+35,016
| +1% | +$1.06M | 0.01% | 534 |
|
|
2022
Q4 | $90.6M | Buy |
3,066,534
+37,398
| +1% | +$1.03M | 0.01% | 513 |
|
|
2022
Q3 | $63.5M | Sell |
3,029,136
-11,490,314
| -79% | -$288M | 0.01% | 588 |
|
|
2022
Q2 | $419M | Sell |
14,519,450
-6,221,220
| -30% | -$210M | 0.05% | 327 |
|
|
2022
Q1 | $755M | Buy |
20,740,670
+19,430,686
| +1,483% | +$590M | 0.08% | 249 |
|
|
2021
Q4 | $31.5M | Buy |
1,309,984
+24,301
| +2% | +$600K | ﹤0.01% | 1154 |
|
|
2021
Q3 | $31.8M | Buy |
1,285,683
+129,894
| +11% | +$2.89M | ﹤0.01% | 1169 |
|
|
2021
Q2 | $26.4M | Buy |
1,155,789
+33,134
| +3% | +$765K | ﹤0.01% | 1231 |
|
|
2021
Q1 | $24.3M | Sell |
1,122,655
-4,291
| -0.4% | -$97.7K | ﹤0.01% | 1227 |
|
|
2020
Q4 | $23.5M | Sell |
1,126,946
-63,330
| -5% | -$1.11M | ﹤0.01% | 1184 |
|
|
2020
Q3 | $15.8M | Sell |
1,190,276
-36,643
| -3% | -$561K | ﹤0.01% | 1204 |
|
|
2020
Q2 | $18.9M | Sell |
1,226,919
-92,189
| -7% | -$1.35M | ﹤0.01% | 1161 |
|
|
2020
Q1 | $13.9M | Buy |
1,319,108
+103,880
| +9% | +$1.95M | ﹤0.01% | 1170 |
|
|
2019
Q4 | $31.1M | Buy |
1,215,228
+68,418
| +6% | +$1.56M | ﹤0.01% | 1053 |
|
|
2019
Q3 | $26.6M | Sell |
1,146,810
-1,256,566
| -52% | -$29.5M | ﹤0.01% | 1065 |
|
|
2019
Q2 | $59.2M | Buy |
2,403,376
+200,986
| +9% | +$4.85M | 0.01% | 820 |
|
|
2019
Q1 | $61M | Buy |
2,202,390
+16,831
| +0.8% | +$425K | 0.01% | 795 |
|
|
2018
Q4 | $47M | Buy |
2,185,559
+202,798
| +10% | +$5.18M | 0.01% | 843 |
|
|
2018
Q3 | $67.1M | Buy |
1,982,761
+22,807
| +1% | +$754K | 0.01% | 798 |
|
|
2018
Q2 | $64.7M | Sell |
1,959,954
-844,097
| -30% | -$28.7M | 0.01% | 783 |
|
|
2018
Q1 | $77.9M | Sell |
2,804,051
-1,818,457
| -39% | -$55.6M | 0.01% | 707 |
|
|
2017
Q4 | $146M | Buy |
4,622,508
+965,041
| +26% | +$31M | 0.02% | 537 |
|
|
2017
Q3 | $134M | Buy |
+3,657,467
| New | +$130M | 0.02% | 546 |
|
Other funds holding BKR
VCM
VPM
T. Rowe Price Associates's BKR Position: Q1 2026 in Review
T. Rowe Price Associates increased its Baker Hughes (BKR) stake by 8.1% in Q1 2026, buying an estimated $54.4M and bringing the position to 12,577,340 shares worth $768M. The position accounts for 0.09% of the portfolio, ranked #183.
T. Rowe Price Associates first reported a position in BKR in Q3 2017 and has held it in 35 quarters since. 1,149 funds tracked by Wall St. Rank hold BKR as of Q1 2026.
- T. Rowe Price Associates held 12,577,340 shares of Baker Hughes worth $768M as of Q1 2026.
- T. Rowe Price Associates bought 941,560 Baker Hughes shares in Q1 2026, an estimated $54.4M.
- Baker Hughes made up 0.09% of T. Rowe Price Associates's portfolio in Q1 2026, its #183 holding.
- T. Rowe Price Associates first reported a position in Baker Hughes in Q3 2017 and has held it in 35 quarters since.
- 1,149 funds tracked by Wall St. Rank held Baker Hughes as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.